Colorectal Carcinoma in the Post-liver-transplant Setting – A Short Overview
recipients and proposal for altered screening, J Gastrointest Surg, 2007;11:272–9.
11. 12. 13. 14. 15.
Herrero JI, Alegre F, Quiroga J, et al., Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report, Clin Transplant, 2009;23:532–6.
Ekbom A, Helmick C, Zack M, Adami HO, Ulcerative colitis and colorectal cancer. A population-based study, N Engl J Med, 1990;323:1228–33.
Lee YM, Kaplan MM, Primary sclerosing cholangitis, N Engl J Med, 1995;332:924–33.
Sugita A, Sachar DB, Bodian C, et al., Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis–cancer interval, Gut, 1991;32:167–9.
Brentnall TA, Haggitt RC, Rabinovitch PS, et al., Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis, Gastroenterology, 1996;110:331–8.
16.
Vera A, Gunson BK, Ussatoff V, et al., Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis, Transplantation, 2003;75:1983–8.
17.
Loftus EV Jr, Aguilar HI, Sandborn WJ, et al., Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation, Hepatology, 1998;27:685–90.
18.
Higashi H, Yanaga K, Marsh JW, et al., Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis, Hepatology, 1990;11:477–80.
19.
Bleday R, Lee E, Jessurun J, Heine J, Wong WD, Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease, Dis Colon Rectum, 1993;36:908–12.
20.
Knechtle SJ, D’Alessandro AM, Harms BA, et al., Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation, Surgery, 1995;118:615–9.
21. 22. 23.
Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL, Liver transplantation for sclerosing cholangitis, Hepatology, 1995;22:451–7.
Fabia R, Levy MF, Testa G, et al., Colon carcinoma in patients undergoing liver transplantation, Am J Surg, 1998;176:265–9.
van de Vrie W, de Man RA, van Buuren HR, et al., Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis, Eur J Gastroenterol Hepatol, 2003;15:657–63.
24.
Broome U, Lofberg R, Lundqvist K, Veress B, Subclinical time span of inflammatory bowel disease in patients
27. 28. 25.
with primary sclerosing cholangitis, Dis Colon Rectum, 1995;38:1301–5.
Collins PD, Mpofu C, Watson AJ, Rhodes JM, Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease, Cochrane Database Syst Rev, 2006:CD000279.
26.
Sint Nicolaas J, de Jonge V, Steyerberg EW, et al., Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis, Am J Transplant, 2010;10:868-76.
Sanchez EQ, Marubashi S, Jung G, et al., De novo tumors after liver transplantation: a single-institution experience, Liver Transpl, 2002;8:285–91.
Jonas S, Rayes N, Neumann U, et al., De novo malignancies after liver transplantation using tacrolimus- based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin, Cancer, 1997;80: 1141–50.
29.
Jain AB, Yee LD, Nalesnik MA, et al., Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data, Transplantation, 1998;66: 1193–200.
30. 31. 32.
Kelly DM, Emre S, Guy SR, et al., Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors, Cancer, 1998;83:1237–43.
Xiol X, Guardiola J, Menendez S, et al., Risk factors for development of de novo neoplasia after liver transplantation, Liver Transpl, 2001;7:971–5.
Oo YH, Gunson BK, Lancashire RJ, et al., Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales, Transplantation, 2005;80: 759–64.
33.
Jiang Y, Villeneuve PJ, Fenton SS, et al., Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study, Liver Transpl, 2008;14: 1588–97.
34. 35. 36. 37.
Albright JB, Bonatti H, Stauffer J, et al., Colorectal and anal neoplasms following liver transplantation, Colorectal Dis, 2010;12:657–66.
Sint Nicolaas J, Tjon AS, Metselaar HJ, et al., Colorectal cancer in post-liver transplant recipients, Dis Colon Rectum, 2010;53:817–21.
Aberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H, Risk of malignant neoplasms after liver transplantation: a population-based study, Liver Transpl, 2008;14:1428–36. Lieberman DA, Weiss DG, Bond JH, et al., Use of
38.
colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Co-operative Study Group 380, N Engl J Med, 2000;343:162–8.
Zaman A, Hapke R, Flora K, Rosen H, Benner K, Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation, Am J Gastroenterol, 1999;94:895–9.
39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49.
Rabinovitz M, Schade RR, Dindzans VJ, et al., Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients, Gastroenterology, 1990;99:195–9.
Gravante G, Delogu D, Venditti D, Upper and lower gastrointestinal diseases in liver transplant candidates, Int J Colorectal Dis, 2008;23:201–6.
Selingo JA, Herrine SK, Weinberg DS, Rubin RA, Role of screening colonoscopy in elective liver transplantation evaluation, Transplant Proc, 1997;29:2506–8.
Weller DA, DeGuide JJ, Riegler JL, Utility of endoscopic evaluations in liver transplant candidates, Am J Gastroenterol, 1998;93:1346–50.
Parikshak M, Pawlak SE, Eggenberger JC, et al., The role of endoscopic colon surveillance in the transplant population, Dis Colon Rectum, 2002;45:1655–60.
Ishikawa S, Kato J, Kuriyama M, et al., Feasibility and findings of colonoscopy for living-donor liver transplant candidates, J Clin Gastroenterol, 2009;43:69–74.
de Jong AE, Morreau H, Nagengast FM, et al., Prevalence of adenomas among young individuals at average risk for colorectal cancer, Am J Gastroenterol, 2005;100:139–43.
Ahmed A, Keeffe EB, Current indications and contraindications for liver transplantation, Clin Liver Dis, 2007;11:227–47.
Penn I, The effect of immunosuppression on pre-existing cancers, Transplantation, 1993;55:742–7.
Koornstra JJ, Wesseling J, de Jong AE, et al., Increased risk of colorectal neoplasia in asymptomatic liver-transplant recipients, Gut, 2007;56:892–3.
Atassi T, Thuluvath PJ, Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy, J Clin Gastroenterol, 2003;37:72–3.
50. 51.
Rudraraju M, Osowo AT, Singh V, Carey EJ, Do patients need more frequent colonoscopic surveillance after liver transplantation?, Transplant Proc, 2008;40:1522–4.
Selgrad M, Koornstra JJ, Fini L, et al., JC virus infection in colorectal neoplasia that develops after liver transplantation, Clin Cancer Res, 2008;14:6717–21.
52. Penn I, Posttransplantation de novo tumors in liver allograft recipients, Liver Transpl Surg, 1996;2:52–9.
EUROPEAN ONCOLOGY
35
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92